Selective regulation of pro-inflammatory genes in macrophages
巨噬细胞中促炎基因的选择性调节
基本信息
- 批准号:8519470
- 负责人:
- 金额:$ 29.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-30 至 2016-07-31
- 项目状态:已结题
- 来源:
- 关键词:Anti-Inflammatory AgentsAnti-inflammatoryAtherosclerosisAutoimmune DiseasesBacterial Artificial ChromosomesBindingCellsChromatinClassification SchemeCommunicationComplexCpG IslandsDataData SetDiseaseFundingFutureGene ActivationGenesGenetic TranscriptionGenomeGoalsIRF3 geneImmuneImmune responseImmune systemImmunityIndividualInfectionInflammatoryInflammatory ResponseInterleukin-10KineticsKnowledgeLaboratoriesLearningLinkLipopolysaccharidesLogicMacrophage ActivationMalignant NeoplasmsMethodologyMethodsModelingMolecularMusNucleosomesPharmaceutical PreparationsPhysiologicalPlayProcessPropertyProtein BiosynthesisProteinsPublishingRNARegulationResolutionReverse Transcriptase Polymerase Chain ReactionRoleSamplingSchemeSeriesShapesSignal PathwayStimulusTissuesTranscriptWorkantimicrobialbasecDNA Librarycell typecytokinegenome-wideinsightmacrophagemicrobialnovelpathogenpromoterresearch studyresponsetranscription factor
项目摘要
DESCRIPTION (provided by applicant): An effective immune response to a microbial pathogen requires extensive communication between cells of the innate and adaptive immune systems. Macrophages and other cells of the innate immune system play a major role in regulating an immune response by expressing hundreds of genes in a well-orchestrated transcriptional cascade after they are stimulated by microbial products or cytokines. An important feature of the transcriptional cascade is that it generally is tailored to the stimulus ad the specific physiological setting. This feature is often beneficial during a normal immune response, but prolonged macrophage activation or aberrant activation can promote tissue damage during infection and has been closely linked to numerous diseases, including cancer, atherosclerosis, and several inflammatory autoimmune diseases. Although anti-inflammatory drugs are available, additional strategies for the selective modulation of individual genes or select subsets of genes are in great demand. Towards the long-term goal of developing methods for the selective modulation of immune and inflammatory responses, a major current objective is to uncover the molecular mechanisms and overall logic by which a robust transcriptional response is orchestrated. We have obtained considerable insight into this regulatory logic by classifying several dozen inducible genes on the basis of their promoter properties and their requirements for new protein synthesis, for the SWI/SNF nucleosome remodeling complex, and for the transcription factor IRF3. Our results led to a model by which some genes contain chromatin and promoter features that allow them to be promiscuously activated by a broad array of stimuli, whereas others contain chromatin and promoter features that facilitate highly selective activation by a limited number of stimuli. More recently, we have taken advantage of state-of-the-art RNAseq methodologies to examine transcriptional cascades at a genome-wide scale. We have also developed a new method in which nascent, chromatin- associated transcripts, nucleoplasmic transcripts, and cytoplasmic transcripts are analyzed separately by RNAseq. This novel method, Nascent-Seq, has allowed us to obtain the highest-resolution view to date of the transcriptional response to an inflammatory stimulus and has allowed us to classify inducible genes on the basis of their nascent transcript kinetics. In Aim 1,
we will perform a large series of additional Nascent-Seq experiments to merge and extend our two distinct schemes for classifying LPS-induced genes. In Aim 2, we will use bacterial artificial chromosomes to determine how CpG-island promoters acquire unique properties that allow them to be regulated in a fundamentally different manner than low CpG promoters. Finally, in Aim 3, we will use the knowledge acquired from our fundamental, genome-scale studies of the macrophage response to examine the molecular mechanisms by which the response is selectively suppressed by the anti-inflammatory cytokine IL-10 and by LPS tolerance induction.
描述(由申请人提供):对微生物病原体的有效免疫反应需要先天免疫系统和适应性免疫系统细胞之间的广泛沟通。巨噬细胞和其他先天免疫系统的细胞在受到微生物产物或细胞因子的刺激后,通过在一个精心安排的转录级联中表达数百个基因,在调节免疫应答中发挥重要作用。转录级联的一个重要特征是,它通常是针对刺激和特定的生理环境量身定制的。在正常的免疫反应中,这一特征通常是有益的,但巨噬细胞的长时间激活或异常激活会在感染期间促进组织损伤,并与许多疾病密切相关,包括癌症、动脉粥样硬化和几种炎症性自身免疫性疾病。虽然抗炎药物是可用的,但对选择性调节单个基因或选择基因亚群的额外策略的需求很大。为了实现开发免疫和炎症反应选择性调节方法的长期目标,当前的主要目标是揭示强有力的转录反应的分子机制和总体逻辑。我们根据启动子特性和对新蛋白合成、SWI/SNF核小体重塑复合体以及转录因子IRF3的需求,对几十个诱导基因进行了分类,从而对这种调控逻辑有了相当深入的了解。我们的结果导致了一个模型,其中一些基因含有染色质和启动子特征,允许它们被广泛的刺激激活,而另一些基因含有染色质和启动子特征,通过有限数量的刺激促进高度选择性激活。最近,我们利用最先进的RNAseq方法在全基因组范围内检查转录级联。我们还开发了一种新的方法,其中新生的,染色质相关转录本,核质转录本和细胞质转录本分别由RNAseq分析。这种新颖的方法,nascent - seq,使我们能够获得迄今为止对炎症刺激的转录反应的最高分辨率视图,并使我们能够根据其新生转录动力学对诱导基因进行分类。在目标1中,
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stephen T Smale其他文献
The establishment and maintenance of lymphocyte identity through gene silencing
通过基因沉默建立和维持淋巴细胞的身份
- DOI:
10.1038/ni0703-607 - 发表时间:
2003-07-01 - 期刊:
- 影响因子:27.600
- 作者:
Stephen T Smale - 通讯作者:
Stephen T Smale
Stephen T Smale的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stephen T Smale', 18)}}的其他基金
FASEB Summer Research Conference on Molecular Mechanisms of Immune Cell Development and Function
FASEB 免疫细胞发育和功能分子机制夏季研究会议
- 批准号:
8907405 - 财政年份:2015
- 资助金额:
$ 29.13万 - 项目类别:
Project 4: Pluripotency and the Marking of Tissue-Specific Genes
项目4:多能性和组织特异性基因的标记
- 批准号:
8520352 - 财政年份:2013
- 资助金额:
$ 29.13万 - 项目类别:
Project 4: Pluripotency and the Marking of Tissue-Specific Genes
项目4:多能性和组织特异性基因的标记
- 批准号:
8382276 - 财政年份:2012
- 资助金额:
$ 29.13万 - 项目类别:
High throughput screens for modulators of inflammatory cytakine gene expression
高通量筛选炎症细胞因子基因表达调节剂
- 批准号:
7842635 - 财政年份:2009
- 资助金额:
$ 29.13万 - 项目类别:
Pioneer factor interactions in embryonic stem cells
胚胎干细胞中先锋因子的相互作用
- 批准号:
7570360 - 财政年份:2009
- 资助金额:
$ 29.13万 - 项目类别:
High throughput screens for modulators of inflammatory cytakine gene expression
高通量筛选炎症细胞因子基因表达调节剂
- 批准号:
7532757 - 财政年份:2009
- 资助金额:
$ 29.13万 - 项目类别:
Pioneer factor interactions in embryonic stem cells
胚胎干细胞中先锋因子的相互作用
- 批准号:
7822893 - 财政年份:2009
- 资助金额:
$ 29.13万 - 项目类别:
Pro-inflammatory gene regulation in a native chromatin environment
天然染色质环境中的促炎基因调控
- 批准号:
8053398 - 财政年份:2008
- 资助金额:
$ 29.13万 - 项目类别:
Pro-inflammatory gene regulation in a native chromatin environment
天然染色质环境中的促炎基因调控
- 批准号:
7467196 - 财政年份:2008
- 资助金额:
$ 29.13万 - 项目类别:
相似海外基金
Nanoplexes for Targeted Anti-Inflammatory Gene Therapy in Atherosclerosis
用于动脉粥样硬化靶向抗炎基因治疗的纳米复合物
- 批准号:
389431 - 财政年份:2018
- 资助金额:
$ 29.13万 - 项目类别:
Operating Grants
The anti-inflammatory mechanism of HDL in atherosclerosis
HDL在动脉粥样硬化中的抗炎机制
- 批准号:
26670411 - 财政年份:2014
- 资助金额:
$ 29.13万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Anti-inflammatory nanoparticle formulations to treat atherosclerosis
治疗动脉粥样硬化的抗炎纳米颗粒制剂
- 批准号:
8696070 - 财政年份:2014
- 资助金额:
$ 29.13万 - 项目类别:
Anti-inflammatory nanoparticle formulations to treat atherosclerosis
治疗动脉粥样硬化的抗炎纳米颗粒制剂
- 批准号:
9279233 - 财政年份:2014
- 资助金额:
$ 29.13万 - 项目类别:
Novel Anti-Inflammatory To Treat Atherosclerosis
治疗动脉粥样硬化的新型抗炎药
- 批准号:
6991086 - 财政年份:2005
- 资助金额:
$ 29.13万 - 项目类别:
Anti-inflammatory Cytokines in Atherosclerosis
动脉粥样硬化中的抗炎细胞因子
- 批准号:
7270467 - 财政年份:2005
- 资助金额:
$ 29.13万 - 项目类别:
Anti-inflammatory Cytokines in Atherosclerosis
动脉粥样硬化中的抗炎细胞因子
- 批准号:
7480215 - 财政年份:2005
- 资助金额:
$ 29.13万 - 项目类别:
Anti-inflammatory Cytokines in Atherosclerosis
动脉粥样硬化中的抗炎细胞因子
- 批准号:
7095164 - 财政年份:2005
- 资助金额:
$ 29.13万 - 项目类别:
Anti-inflammatory Cytokines in Atherosclerosis
动脉粥样硬化中的抗炎细胞因子
- 批准号:
6984242 - 财政年份:2005
- 资助金额:
$ 29.13万 - 项目类别:
Anti-inflammatory Cytokines in Atherosclerosis
动脉粥样硬化中的抗炎细胞因子
- 批准号:
7996469 - 财政年份:2005
- 资助金额:
$ 29.13万 - 项目类别: